Imaging of Dopaminergic System in Movement Disorders / 핵의학분자영상
Nuclear Medicine and Molecular Imaging
;
: 132-140, 2007.
Artículo
en Coreano
| WPRIM
| ID: wpr-225213
ABSTRACT
Parkinson's disease is a common neurodegenerative disorder that is mainly caused by dopaminergic neuron loss in the substantia nigra. Several radiopharmaceutics have been developed to evaluate the integrity of dopaminergic neuronal system. In vivo PET and SPECT imaging of presynaptic dopamine imaing are already applied to Parkinson's disease and other parkinsonism, and can demonstrate the dopaminergic dysfunction. This review summarized the use of the presynaptic dopaminergic imaging in PD as biomarkers in evaluation of disease progression as well as in diagnosis of PD.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Enfermedad de Parkinson
/
Sustancia Negra
/
Biomarcadores
/
Dopamina
/
Tomografía Computarizada de Emisión de Fotón Único
/
Progresión de la Enfermedad
/
Enfermedades Neurodegenerativas
/
Trastornos Parkinsonianos
/
Diagnóstico
/
Neuronas Dopaminérgicas
Tipo de estudio:
Estudio diagnóstico
Idioma:
Coreano
Revista:
Nuclear Medicine and Molecular Imaging
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS